AstraZeneca and Amgen’s Tezspire has met both co-primary and key [...]

Tagomics has launched a cell-free DNA platform designed to monitor [...]

AstraZeneca’s Trixeo Aerosphere has been recommended for approval in the [...]

Kairos Pharma has reported positive interim safety results from an [...]

AstraZeneca is presenting a broad package of new clinical and [...]

AstraZeneca’s Imfinzi (durvalumab) has been recommended by NICE for use [...]

The National Institute for Health and Care Excellence (NICE) has [...]

Tozorakimab has met its primary endpoint in two replicate Phase [...]

AstraZeneca has received a positive recommendation from the Committee for [...]

Immunai has signed an agreement worth up to $85 million [...]